Search for: "Bristol-Myers Squibb Co. et al v. Mylan Pharmaceuticals Inc. et al" Results 1 - 13 of 13
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Dec 2009, 9:59 am by Karen E. Keller
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/28: Bristol-Myers Squibb Co., Bristol-Myers Squibb Pharma Co. v. [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical Companies, Inc. et al (Patent Docs) Baraclude (Entecavir) – US: Patent infringement complaint filed following Paragraph IV certification: Bristol-Myers Squibb Co. v. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) Reyataz (Atazanavir): US: Patent infringement complaint filed following a Paragraph IV certification: Bristol-Myers Squibb Co. et al. v. [read post]
18 Aug 2010, 12:19 am by Kelly
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
24 Nov 2010, 12:37 am by Kelly
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]